SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-23-069098
Filing Date
2023-12-08
Accepted
2023-12-08 17:26:27
Documents
7
Period of Report
2023-12-08

Document Format Files

Seq Description Document Type Size
1 PRE 14A pre14a_2024reversesplits.htm PRE 14A 320344
2 GRAPHIC img162656983_0.jpg GRAPHIC 12897
3 GRAPHIC img162656983_1.jpg GRAPHIC 5049
4 GRAPHIC img162656983_2.jpg GRAPHIC 6824
5 GRAPHIC img162656983_3.jpg GRAPHIC 5183
6 GRAPHIC img162656983_4.jpg GRAPHIC 389843
7 GRAPHIC img162656983_5.jpg GRAPHIC 175438
  Complete submission text file 0000950170-23-069098.txt   1141345
Mailing Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104
Business Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104 605-679-6980
SAB Biotherapeutics, Inc. (Filer) CIK: 0001833214 (see all company filings)

IRS No.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39871 | Film No.: 231476418
SIC: 2836 Biological Products, (No Diagnostic Substances)